These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16517745)

  • 1. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus.
    Munks MW; Gold MC; Zajac AL; Doom CM; Morello CS; Spector DH; Hill AB
    J Immunol; 2006 Mar; 176(6):3760-6. PubMed ID: 16517745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.
    Holtappels R; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ
    Med Microbiol Immunol; 2015 Jun; 204(3):317-26. PubMed ID: 25805564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
    Munks MW; Pinto AK; Doom CM; Hill AB
    J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens.
    Dekhtiarenko I; Jarvis MA; Ruzsics Z; Čičin-Šain L
    J Immunol; 2013 Apr; 190(7):3399-409. PubMed ID: 23460738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo.
    Gold MC; Munks MW; Wagner M; Koszinowski UH; Hill AB; Fling SP
    J Immunol; 2002 Jul; 169(1):359-65. PubMed ID: 12077265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.
    Simon CO; Holtappels R; Tervo HM; Böhm V; Däubner T; Oehrlein-Karpi SA; Kühnapfel B; Renzaho A; Strand D; Podlech J; Reddehase MJ; Grzimek NK
    J Virol; 2006 Nov; 80(21):10436-56. PubMed ID: 16928768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells.
    Holtappels R; Thomas D; Podlech J; Geginat G; Steffens HP; Reddehase MJ
    J Virol; 2000 Feb; 74(4):1871-84. PubMed ID: 10644360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.
    Munks MW; Cho KS; Pinto AK; Sierro S; Klenerman P; Hill AB
    J Immunol; 2006 Jul; 177(1):450-8. PubMed ID: 16785542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the Dynamics of MCMV-Specific CD8
    Gabel M; Baumann NS; Oxenius A; Graw F
    Front Immunol; 2019; 10():1358. PubMed ID: 31281313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition.
    Lyons PA; Allan JE; Carrello C; Shellam GR; Scalzo AA
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2615-23. PubMed ID: 8887498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection.
    Farrington LA; Smith TA; Grey F; Hill AB; Snyder CM
    J Immunol; 2013 Apr; 190(7):3410-6. PubMed ID: 23455500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection.
    Snyder CM; Loewendorf A; Bonnett EL; Croft M; Benedict CA; Hill AB
    J Immunol; 2009 Sep; 183(6):3932-41. PubMed ID: 19692644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
    Ye M; Morello CS; Spector DH
    J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response.
    Gold MC; Munks MW; Wagner M; McMahon CW; Kelly A; Kavanagh DG; Slifka MK; Koszinowski UH; Raulet DH; Hill AB
    J Immunol; 2004 Jun; 172(11):6944-53. PubMed ID: 15153514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus.
    Hutchinson S; Sims S; O'Hara G; Silk J; Gileadi U; Cerundolo V; Klenerman P
    PLoS One; 2011 Feb; 6(2):e14646. PubMed ID: 21304910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection.
    Walton SM; Wyrsch P; Munks MW; Zimmermann A; Hengel H; Hill AB; Oxenius A
    J Immunol; 2008 Jul; 181(2):1128-34. PubMed ID: 18606665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype.
    Holtappels R; Thomas D; Podlech J; Reddehase MJ
    J Virol; 2002 Jan; 76(1):151-64. PubMed ID: 11739681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stochastic Episodes of Latent Cytomegalovirus Transcription Drive CD8 T-Cell "Memory Inflation" and Avoid Immune Evasion.
    Griessl M; Renzaho A; Freitag K; Seckert CK; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():668885. PubMed ID: 33968074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
    Morello CS; Ye M; Spector DH
    J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.